ISSN 1070-3632, Russian Journal of General Chemistry, 2012, Vol. 82, No. 1, pp. 153–156. © Pleiades Publishing, Ltd., 2012.
Original Russian Text © A.V. Erkin, V.I. Krutikov, A.A. Ivanov, 2012, published in Zhurnal Obshchei Khimii, 2012, Vol. 82, No. 1, pp. 156–159.
Synthesis and Tuberculocidic Activity
of Some 4-Arylaminomethylene-3-methyl-
1-(pyrimidin-2-yl)pyrazol-5(4H)-ones
A. V. Erkin, V. I. Krutikov, and A. A. Ivanov
St. Petersburg State Institute of Technology, Moskovskii pr. 26, St. Petersburg, 190013 Russia
e-mail: kruerk@yandex.ru
Received April 26, 2011
Abstract—4-Arylaminomethylene-3-methyl-1-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)pyrazol-5(4H)-
ones were synthesized by a three-component reaction between the 6-methyl-2-(3-methyl-5-oxo-2,5-
dihydropyrazol-1-yl)pyrimidin-4(1H)-one, triethoxymethane, and an aromatic amine. These compounds were
found to exist as aminomethyleneketones regardless of the electronic effects of substituents in the aromatic
fragments. The resulting compounds showed pronounced tuberculocidic activity.
DOI: 10.1134/S1070363212010252
Ar
The detected ability of some 4-arylidene-3-methyl-
1-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)pyrazol-
5(4H)-ones (I) to inhibit the Mycobacterium
tuberculosis cell growth [1] stimulates a search for the
substances with similar effects among the structurally
similar compounds. The modification of arylidene-
pyrazolones I through fusing pyrimidine and cyclo-
pentane rings led to the loss of tuberculocidic
properties in the obtained 4-arylidene-3-methyl-1-(4-
oxo-3,4-dihydrocyclopenta[d]pyrimidin-2-yl)-pyrazol-
5(4H)-ones [2]. The extension of the series of com-
pounds I by varying the substituents in the aromatic
ring was found to be hindered because the condensation
of the initial ethyl acetoacetate (6-methyl-4-oxo-3,4-
dihydropyrimidin-2-yl)ethyl hydrazone [3] or 6-methyl-
2-(3-methyl-5-oxo-2,5-dihydropyrazol-1-yl) pyrimidin-
4(1H)-one III [4] with aromatic aldehydes leds to the
products of the desired structure only with the reagents
containing an auxochromic substituent in the para-
position of the ring. The arylidenepyrazolone analogs
of I with the minimally transformed structure are 4-
arylaminomethylene-3-methyl-1-(6-methyl-4-oxo-1,4-
dihydropyrimidin-2-yl)pyrazol-5(4H)-ones (IVa–IVk).
In order to study their tuberculocidic action we have
synthesised these compounds by a three-component
reaction between the pyrazolone (III), triethoxy-
methane, and aromatic amines.
Me
NH
N
H
Me
N
O
O
(EtO)3CH + ArNH2
N
N
HN
N
HN
N
Me
O
Me
O
III
IVа_IVk
solvent till the solidification of the reaction mixture.
When the mixture did not solidify despite an increase
in the time of contact of the initial compounds, the
formed thick oil was treated with benzene to cause the
product crystallization. To purify arylaminomethylene-
pyrazolones IVa–IVk obtained they were crystallized
once or twice from a suitable solvent or solvent
mixture, to reach chromatographic purity of the target
compound (Table 1).
Structure of arylaminomethylenepyrazolones IV is
confirmed by the data of the H NMR spectra, which
1
contain multiplets of aromatic protons in the region of
7.2–7.9 ppm, as well as the characteristic doublets of
protons of exocyclic CH groups near 8.5 ppm and NH
about 11.0 ppm. In some cases the signals of
secondary exocyclic amino groups appear as an
unresolved singlet. Table 2 lists more detailed spectral
parameters of compounds IVa–IVk.
The reaction was performed by heating the
equimolar mixture of reagents at 70–80°C without a
153